PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
+19.2%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$16.2B
AUM Growth
+$16.2B
(+20%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-7.2%
Top 10 Holdings %
Top 10 Hldgs %
36.46%
Holding
322
New
36
Increased
65
Reduced
120
Closed
37
Top Buys
| 1 |
Micron Technology
MU
|
$156M |
| 2 |
Netflix
NFLX
|
$127M |
| 3 |
Cadence Design Systems
CDNS
|
$95.9M |
| 4 |
Elastic
ESTC
|
$81.5M |
| 5 |
Broadcom
AVGO
|
$80.5M |
Top Sells
| 1 |
Microsoft
MSFT
|
$173M |
| 2 |
Ferguson
FERG
|
$132M |
| 3 |
Meta Platforms (Facebook)
META
|
$131M |
| 4 |
NVIDIA
NVDA
|
$111M |
| 5 |
Cytokinetics
CYTK
|
$103M |
Sector Composition
| 1 | Technology | 38.47% |
| 2 | Healthcare | 18.68% |
| 3 | Financials | 14.69% |
| 4 | Industrials | 12.48% |
| 5 | Communication Services | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Boston Scientific
BSX
$158B
| $58.6M | 0.36% |
1,013,105
+351,659
| +53% | +$20.3M |
|
77
monday.com
MNDY
$9.66B
| $58.5M | 0.36% |
311,736
-120,002
| -28% | -$22.5M |
|
78
Pinduoduo
PDD
$173B
| $57.3M | 0.35% |
391,378
-65,870
| -14% | -$9.64M |
|
79
Axon Enterprise
AXON
$58.4B
| $57.2M | 0.35% |
221,598
-43,866
| -17% | -$11.3M |
|
80
MoonLake Immunotherapeutics
MLTX
$3.72B
| $56.6M | 0.35% |
937,115
-1,897
| -0.2% | -$115K |
|
81
Supernus Pharmaceuticals
SUPN
$2.5B
| $56.1M | 0.34% |
1,939,365
+284,895
| +17% | +$8.24M |
|
82
Elevance Health
ELV
$72.6B
| $56.1M | 0.34% |
118,996
-18,348
| -13% | -$8.65M |
|
83
AbbVie
ABBV
$374B
| $56.1M | 0.34% |
361,808
-5,064
| -1% | -$785K |
|
84
Ryan Specialty Holdings
RYAN
$7.1B
| $55.4M | 0.34% |
1,287,500
| – | – |
|
85
Scholar Rock
SRRK
$3.18B
| $55.3M | 0.34% |
2,940,672
+1,438,746
| +96% | +$27M |
|
86
Berkshire Hathaway Class B
BRK.B
$1.08T
| $55.2M | 0.34% |
154,786
-2,064
| -1% | -$736K |
|
87
Mercado Libre
MELI
$121B
| $49.6M | 0.3% |
31,543
+4,583
| +17% | +$7.2M |
|
88
First American
FAF
$6.56B
| $45.1M | 0.28% |
700,000
| – | – |
|
89
JPMorgan Chase
JPM
$824B
| $44.2M | 0.27% |
259,875
-1,402
| -0.5% | -$238K |
|
90
MakeMyTrip
MMYT
$9.1B
| $43M | 0.26% |
915,452
+100,474
| +12% | +$4.72M |
|
91
CRH
CRH
$74.7B
| $41.8M | 0.26% |
604,197
-52,019
| -8% | -$3.6M |
|
92
Globant
GLOB
$2.83B
| $40.1M | 0.25% |
168,508
+16,393
| +11% | +$3.9M |
|
93
Aflac
AFL
$56.5B
| $40M | 0.25% |
485,000
-15,000
| -3% | -$1.24M |
|
94
Hagerty
HGTY
$1.12B
| $38.4M | 0.24% |
4,925,000
+343,295
| +7% | +$2.68M |
|
95
Trupanion
TRUP
$1.94B
| $38.1M | 0.23% |
1,250,000
| – | – |
|
96
Pliant Therapeutics
PLRX
$103M
| $36.5M | 0.22% |
2,015,000
+350,000
| +21% | +$6.34M |
|
97
Merit Medical Systems
MMSI
$5.37B
| $36.3M | 0.22% |
478,342
| – | – |
|
98
Abbott
ABT
$229B
| $35.8M | 0.22% |
+325,000
| New | +$35.8M |
|
99
Linde
LIN
$222B
| $35.5M | 0.22% |
86,317
-5,385
| -6% | -$2.21M |
|
100
Alnylam Pharmaceuticals
ALNY
$58.6B
| $35.4M | 0.22% |
185,000
-50,000
| -21% | -$9.57M |
|